Growth Metrics

Mannkind (MNKD) Enterprise Value (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.44%
Dec 31, 2025 34.11%
Sep 30, 2025 -45.28%
Jun 30, 2025 1.81%
Mar 31, 2025 7.94%
Dec 31, 2024 21.53%
Sep 30, 2024 -1.54%
Jun 30, 2024 17.37%
Mar 31, 2024 -1.91%
Dec 31, 2023 -109.27%
Sep 30, 2023 2.31%
Jun 30, 2023 13.12%
Mar 31, 2023 2.75%
Dec 31, 2022 -3.51%
Sep 30, 2022 -7.07%
Jun 30, 2022 5.08%
Mar 31, 2022 20.44%
Dec 31, 2021 -46.83%
Sep 30, 2021 14.44%
Jun 30, 2021 41.31%
Mar 31, 2021 -312.18%
Dec 31, 2020 -27.41%
Sep 30, 2020 17.04%
Jun 30, 2020 -63.47%
Mar 31, 2020 22.12%
Dec 31, 2019 0.30%
Sep 30, 2019 -276.83%
Jun 30, 2019 77.60%
Mar 31, 2019 17.28%
Dec 31, 2018 -553.28%
Sep 30, 2018 58.91%
Jun 30, 2018 1.94%
Mar 31, 2018 43.68%
Dec 31, 2017 -383.55%
Sep 30, 2017 76.95%
Jun 30, 2017 9.58%
Mar 31, 2017 -109.56%
Dec 31, 2016 35.56%
Sep 30, 2016 44.25%
Jun 30, 2016 -130.47%
Mar 31, 2016 53.19%
Dec 31, 2015 -79.40%
Sep 30, 2015 69.28%
Jun 30, 2015 11.30%
Mar 31, 2015 0.00%
Dec 31, 2014 29.93%
Sep 30, 2014 -318.46%
Jun 30, 2014 -15.25%
Mar 31, 2014 49.49%
Dec 31, 2013 24.53%
Sep 30, 2013 -228.80%
Jun 30, 2013 -1.87%
Mar 31, 2013 54.71%
Dec 31, 2012 -2,823.88%
Sep 30, 2012 93.39%
Jun 30, 2012 43.59%
Mar 31, 2012 -1,674.25%
Dec 31, 2011 86.28%
Sep 30, 2011 7.79%
Jun 30, 2011 46.14%
Mar 31, 2011 33.39%
Dec 31, 2010 28.08%
Sep 30, 2010 -245.33%